"Testicular Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.
| Descriptor ID |
D013736
|
| MeSH Number(s) |
C04.588.322.762 C04.588.945.440.915 C12.294.260.937 C12.758.409.937 C19.344.762 C19.391.829.782
|
| Concept/Terms |
Testicular Neoplasms- Testicular Neoplasms
- Neoplasm, Testicular
- Testicular Neoplasm
- Testicular Tumors
- Testis Neoplasms
- Neoplasms, Testicular
- Neoplasms, Testis
- Neoplasm, Testis
- Testis Neoplasm
Tumor of Rete Testis- Tumor of Rete Testis
- Rete Testis Tumor
- Rete Testis Tumors
- Testis Tumor, Rete
- Testis Tumors, Rete
Cancer of Testis- Cancer of Testis
- Testis Cancers
- Testis Cancer
- Cancer, Testis
- Cancers, Testis
- Cancer of the Testes
- Cancer of the Testis
- Testicular Cancer
- Cancer, Testicular
- Cancers, Testicular
- Testicular Cancers
|
Below are MeSH descriptors whose meaning is more general than "Testicular Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Testicular Neoplasms".
This graph shows the total number of publications written about "Testicular Neoplasms" by people in this website by year, and whether "Testicular Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 5 | 0 | 5 |
| 2008 | 3 | 1 | 4 |
| 2009 | 4 | 0 | 4 |
| 2010 | 3 | 0 | 3 |
| 2011 | 5 | 0 | 5 |
| 2012 | 3 | 0 | 3 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 1 | 3 |
| 2016 | 6 | 0 | 6 |
| 2017 | 4 | 1 | 5 |
| 2018 | 5 | 0 | 5 |
| 2019 | 10 | 0 | 10 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 6 | 1 | 7 |
| 2023 | 6 | 1 | 7 |
| 2024 | 6 | 1 | 7 |
| 2025 | 5 | 0 | 5 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Testicular Neoplasms" by people in Profiles.
-
Robotic versus open post-chemotherapy retroperitoneal lymph node dissection: a propensity score matched study across 11 academic medical centers. World J Urol. 2026 Aug 28; 44(1).
-
Safety of omitting pelvic imaging in patients with stage I germ cell tumor (GCT) on surveillance: A multi-institutional study. Urol Oncol. 2026 Mar; 44(3):110966.
-
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer Survivors. Cancer Med. 2025 Sep; 14(17):e71218.
-
Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologists. Histopathology. 2025 Nov; 87(5):677-686.
-
Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial. J Urol. 2025 09; 214(3):272-279.
-
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025. J Natl Compr Canc Netw. 2025 04; 23(4).
-
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour. BJU Int. 2025 Apr; 135(4):621-628.
-
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study. Eur Urol Focus. 2025 Mar; 11(2):266-272.
-
Overcoming the Code Duello: Achieving Long-term Cure and Optimizing Quality of Life in Testicular Cancer. Eur Urol Focus. 2024 05; 10(3):355-356.
-
Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy. JAMA Oncol. 2024 Jul 01; 10(7):912-922.